Sagimet Biosciences Inc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: Sagimet Biosciences Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Sagimet Biosciences Inc - Ordinary Shares - Class A
Rating: 2.00508325
Author: Trendlyne DVM scores

about

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolis...

9.15 0.47 (5.41%)

428.90% Gain from 52W Low

821.9K

XNAS Volume

XNAS 08 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

8.3 / 100

Technically Bullish

71.9 / 100

1Yr Price target upside is 233%

8 analysts

Sagimet Biosciences Inc - ... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Sagimet Biosciences Inc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolis...

428.90% Gain from 52W Low

SWOT Analysis

Sagimet Biosciences Inc - ... Live Price Chart